We identified Car3 as a protein increased in the liver in a mouse model fed high-fat diet but lowered with niclosamide (Fig 2), a drug shown to improve fatty liver and T2D-like symptoms [47]. This evidence concerns the gene CA3 and type 2 diabetes mellitus.